An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects with Genotypes 1 - 6 Chronic Hepatitis C Virus (HCV) Infection
The purpose of this study is to measure study drug levels in the bloodstream of children who are between the ages of 3 to 17 years old at the time of enrollment and to determine if the study drugs are safe and able to reduce th ...